RE:RE:RE:Let me show you a slice of reality...Not sure I would call it "disruptive" as I would call it new. But substantively we are talking about the same thing. That is the beauty of it, but is a challenge as well. Challenge in terms of quick and broad adoption. It is difficult to get it when people don't know about it or cannot fully envision the benefit. I think that is what is holding us back, need a few bigger players to kick the tires, experience it and then have an a-ha story in terms of how to best use it that can be described to others. We, and probably KNR, hoped that the Covid would give it that kickstart to not putt around as long as getting to figure a lot of things out, but it did not. The pace still may be fast behind the scenes in terms of which of their clients are piloting it, because sometimes it takes you months and years to get your clients to try something new. Markets are funny that way - there are companies that have much larger market caps with lesser results and less exciting future potential. KNR will have to earn its larger valuation unfortunately, and so we have to be more patient.
yearninyank wrote: Biocloud is disruptive technology. That is the beauty of it.